Head & Neck Cancer

Cancer patients are living longer, but if radiation was part of their treatment, late effects may be a problem.

The insecurity and insight that come from cancer's battle scars.

Chronic inflammation causes cancer. Find out how and what's being done about it.

A number of diagnostic, prognostic, or predictive tests can help determine the optimal course of treatment by using predictive markers from the patient’s or tumor’s genetic information.

Minimally invasive technologies transform the landscape of cancer surgery.

Updates from the 2007 meeting of the American Society of Clinical Oncology includes news on liver, kidney, lung, colon, pancreatic and breast cancers.

New approvals for colorectal, lung, breast, head & neck cancer and lymphoma.

Updates from the 2006 annual meeting of the American Society of Clinical Oncology.

Revlimid is approved for certain types of myelodysplastic syndrome, and Sutent was approved for both advanced kidney cancer and gastrointestinal stromal tumor.

New therapies may turn the tide for this disfiguring cancer.